Related Experiment Video
Updated: Sep 19, 2025

A Bioinformatics Pipeline for Investigating Molecular Evolution and Gene Expression using RNA-seq
Published on: May 28, 2021
The role of MYEOV gene: a review and future directions
Yidan Xi1, Xuefei Liu1, Yanan Ge1
1Department of Oncology, General Hospital of Northern Theater Command, Shenyang, China.
Abstract:
The overexpressed gene MYEOV in multiple myeloma, as an oncogene, has been widely recognized for its high expression levels in various malignant tumors. MYEOV plays a significant role in multiple malignancies, particularly in diseases such as multiple myeloma, breast cancer, lung cancer, pancreatic cancer, and esophageal cancer. The presence of the open reading frame of MYEOV in humans and other primates suggests its potential protein-coding capacity, although direct evidence of functional MYEOV protein is currently lacking. The role of MYEOV in various tumors is not limited to its direct effects as an oncogene; it also includes its complex role in tumor cell signaling pathways and its ability to participate in miRNA regulatory networks as a competing endogenous RNA (ceRNA). Studies have shown that MYEOV may affect the expression of cancer-related genes through enhancer activity. This article aims to provide a comprehensive review of the role of MYEOV, its involvement in signaling pathways in tumor cells, and the latest advancements in MYEOV-targeted therapies.
Insights
The overexpressed gene MYEOV functions as an oncogene in multiple cancers, including multiple myeloma. This review covers MYEOV
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- The MYEOV gene is frequently overexpressed in various cancers, acting as an oncogene.
- MYEOV is implicated in multiple malignancies, including multiple myeloma, breast cancer, lung cancer, pancreatic cancer, and esophageal cancer.
- While MYEOV has an open reading frame in primates, direct evidence of its functional protein is limited.
Purpose of the Study:
- To comprehensively review the role of the MYEOV oncogene in tumor development.
- To explore MYEOV's involvement in cancer cell signaling pathways and miRNA regulatory networks.
- To discuss recent advancements in MYEOV-targeted cancer therapies.
Main Methods:
- Literature review of studies on MYEOV expression and function in cancer.
- Analysis of MYEOV's role in oncogenesis, signaling pathways, and miRNA interactions.
- Examination of current and emerging therapeutic strategies targeting MYEOV.
Main Results:
- MYEOV's oncogenic activity is linked to its high expression in tumors.
- MYEOV influences tumor cell signaling and acts as a competing endogenous RNA (ceRNA).
- MYEOV may regulate cancer-related genes via enhancer activity.
Conclusions:
- MYEOV is a significant oncogene with a multifaceted role in cancer progression.
- Understanding MYEOV's mechanisms is crucial for developing effective cancer treatments.
- Targeted therapies against MYEOV show promise for managing various malignancies.
Related Concept Videos
Gene Therapy
Regulation of Expression at Multiple Steps
Microorganisms in Medicine and Therapeutics
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...
Eukaryotic Evolution
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Animal Mitochondrial Genetics

